vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and HighPeak Energy, Inc. (HPK). Click either name above to swap in a different company.
HighPeak Energy, Inc. is the larger business by last-quarter revenue ($216.6M vs $168.4M, roughly 1.3× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -23.3%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -13.2%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Duke Energy Corporation is an American electric power and natural gas holding company headquartered in Charlotte, North Carolina. The company serves over 7 million customers in the eastern United States. In 2024 it ranked as the 141st largest company in the United States – its highest-ever placement on the Fortune 500 list.
ESPR vs HPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $216.6M |
| Net Profit | — | $-25.2M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | -7.6% |
| Net Margin | — | -11.6% |
| Revenue YoY | 143.7% | -23.3% |
| Net Profit YoY | — | -380.7% |
| EPS (diluted) | $0.32 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $216.6M | ||
| Q3 25 | $87.3M | $188.9M | ||
| Q2 25 | $82.4M | $200.4M | ||
| Q1 25 | $65.0M | $257.4M | ||
| Q4 24 | $69.1M | $282.6M | ||
| Q3 24 | $51.6M | $271.6M | ||
| Q2 24 | $73.8M | $275.3M | ||
| Q1 24 | $137.7M | $287.8M |
| Q4 25 | — | $-25.2M | ||
| Q3 25 | $-31.3M | $-18.3M | ||
| Q2 25 | $-12.7M | $26.2M | ||
| Q1 25 | $-40.5M | $36.3M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-29.5M | $49.9M | ||
| Q2 24 | $-61.9M | $29.7M | ||
| Q1 24 | $61.0M | $6.4M |
| Q4 25 | 50.6% | -7.6% | ||
| Q3 25 | -11.4% | 17.3% | ||
| Q2 25 | 8.6% | 21.7% | ||
| Q1 25 | -34.0% | 35.1% | ||
| Q4 24 | -6.4% | 26.1% | ||
| Q3 24 | -31.0% | 27.0% | ||
| Q2 24 | 3.5% | 31.7% | ||
| Q1 24 | 52.5% | 35.8% |
| Q4 25 | — | -11.6% | ||
| Q3 25 | -35.9% | -9.7% | ||
| Q2 25 | -15.4% | 13.1% | ||
| Q1 25 | -62.2% | 14.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -57.2% | 18.4% | ||
| Q2 24 | -83.9% | 10.8% | ||
| Q1 24 | 44.3% | 2.2% |
| Q4 25 | $0.32 | $-0.16 | ||
| Q3 25 | $-0.16 | $-0.15 | ||
| Q2 25 | $-0.06 | $0.19 | ||
| Q1 25 | $-0.21 | $0.26 | ||
| Q4 24 | $-0.14 | $0.06 | ||
| Q3 24 | $-0.15 | $0.35 | ||
| Q2 24 | $-0.33 | $0.21 | ||
| Q1 24 | $0.34 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $162.1M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $-302.0M | $1.6B |
| Total Assets | $465.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 0.75× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $162.1M | ||
| Q3 25 | $92.4M | $164.9M | ||
| Q2 25 | $86.1M | $21.9M | ||
| Q1 25 | $114.6M | $51.6M | ||
| Q4 24 | $144.8M | $86.6M | ||
| Q3 24 | $144.7M | $135.6M | ||
| Q2 24 | $189.3M | $157.9M | ||
| Q1 24 | $226.6M | $173.4M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $-302.0M | $1.6B | ||
| Q3 25 | $-451.4M | $1.6B | ||
| Q2 25 | $-433.5M | $1.7B | ||
| Q1 25 | $-426.2M | $1.6B | ||
| Q4 24 | $-388.7M | $1.6B | ||
| Q3 24 | $-370.2M | $1.6B | ||
| Q2 24 | $-344.2M | $1.6B | ||
| Q1 24 | $-294.3M | $1.5B |
| Q4 25 | $465.9M | $3.2B | ||
| Q3 25 | $364.0M | $3.2B | ||
| Q2 25 | $347.1M | $3.1B | ||
| Q1 25 | $324.0M | $3.1B | ||
| Q4 24 | $343.8M | $3.1B | ||
| Q3 24 | $314.1M | $3.1B | ||
| Q2 24 | $352.3M | $3.1B | ||
| Q1 24 | $373.1M | $3.1B |
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.73× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $93.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $93.1M | ||
| Q3 25 | $-4.3M | $120.2M | ||
| Q2 25 | $-31.4M | $141.2M | ||
| Q1 25 | $-22.6M | $157.1M | ||
| Q4 24 | $-35.0M | $139.5M | ||
| Q3 24 | $-35.3M | $177.1M | ||
| Q2 24 | $-7.2M | $202.3M | ||
| Q1 24 | $53.8M | $171.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 5.39× | ||
| Q1 25 | — | 4.32× | ||
| Q4 24 | — | 15.53× | ||
| Q3 24 | — | 3.55× | ||
| Q2 24 | — | 6.81× | ||
| Q1 24 | 0.88× | 26.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
HPK
| Crude Oil Sales | $152.1M | 70% |
| Natural Gas And NGL Sales | $60.8M | 28% |
